ROHM (TSE:6963) Valuation Focused as New Power Devices Target AI Server and Industrial Growth

ROHM (TSE:6963) just announced two new products aimed at boosting efficiency and reliability in fast-growing segments such as AI servers and industrial power systems. Mass production is already underway for both devices.

See our latest analysis for ROHM.

ROHM has generated buzz this year, with recent product launches clearly resonating in sectors eager for next-generation efficiency. The stock has delivered a robust 49.2% total shareholder return over the past year, despite a short-term dip in the last month. There is genuine momentum behind the long-term story, as excitement over AI hardware and energy-saving technology starts to find its way into the share price.

If ROHM’s moves in power electronics have you watching the sector, the next step is to check out other leaders using our tech and AI stock discovery list See the full list for free.

But with so much optimism riding on new technology and sector tailwinds, is ROHM’s valuation reflecting real future upside, or is the market already pricing in tomorrow’s growth? Could now be a genuine buying opportunity?

Most Popular Narrative: 6% Undervalued

Compared to the last close price of ¥2,089.5, the most popular narrative indicates ROHM still trades at a modest discount to its fair value. Momentum in technology and power devices, along with improved analyst forecasts, is helping to shape this perspective.

Strategic partnerships, such as with DENSO and potential alliances with Toshiba, are expected to enhance collaborative opportunities and could lead to steady revenue increases and strengthen competitive positioning in the semiconductor market.

Read the complete narrative.

This narrative hinges on bold expansion plans, major partnerships, and ambitious upgrades to ROHM's profit targets. Want to know which forecasted growth rates and financial milestones are driving this lofty fair value? Find out the key numbers behind the headline and which aggressive assumptions set this narrative apart.

Result: Fair Value of ¥2,222.73 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still clear risks. Persistent weakness in industrial demand or further delays in cost reductions could quickly undermine this optimistic outlook.

Find out about the key risks to this ROHM narrative.

Another View: Our DCF Model Paints a Different Picture

While the prevailing narrative suggests ROHM is undervalued, the SWS DCF model gives a much more cautious result. According to the DCF, the current share price sits well above our estimate of fair value. Could the market be overestimating future cash flow growth? Is this optimism justified?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out ROHM for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 932 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own ROHM Narrative

If you have a different perspective or want to dive deeper into the numbers yourself, you can build your own view in just a few minutes using Do it your way.

A great starting point for your ROHM research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Expand your portfolio with inspired opportunities beyond ROHM. Use these expert-curated lists to spot tomorrow’s winners and stay ahead before trends take off.

• Uncover hidden value in companies that offer strong fundamentals and attractive pricing by starting with these 932 undervalued stocks based on cash flows.
• Tap into the future of healthcare innovation and see which businesses are set to transform patient care through breakthroughs found in these 30 healthcare AI stocks.
• Accelerate your growth strategy by following these 25 AI penny stocks, where market leaders are pushing boundaries in automation and advanced intelligence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com